CORE SCIENTIFIC INC

Insider selling at Core Scientific: Director Duchene Todd M offloads >$200k of shares amid a pivot to AI infrastructure and a new AMD partnership—what investors should watch.

Core Scientific insider Todd DuChene sells 10k shares under a Rule 10b5‑1 plan—signal of disciplined profit‑taking amid volatile market trends. Click to learn how this may affect investor confidence and the company’s future prospects.

CEO Sullivan Adam Taylor’s July 2026 insider sale of 15,584 Core Scientific shares at $22.72 sparks investor curiosity—why now, what it signals for the stock’s future, and how it fits into a broader liquidity strategy.

Insider selling surge at Core Scientific: Todd Duchene trims 2M shares amid market decline, raising questions on short‑term confidence and potential buying opportunity.

Core Scientific insider Todd M. Duchene sells 10k shares as the stock climbs—does this signal a shift in confidence or routine liquidity? Discover the impact for investors.

Insider Todd M. Duchene’s 10,000‑share sale of Core Scientific Inc. reveals a disciplined, rule‑based liquidation amid a volatile market, offering investors insight into potential liquidity impacts while underscoring ongoing confidence in the compan…

Core Scientific CFO James Nygaard receives a 120k‑share RSU grant, balancing insider sales with long‑term stakes – what this means for investors and the company’s AI‑focused growth.

Core Scientific insider Todd DuChene’s May 18 sell‑off reveals a deliberate, rule‑based trimming of 200k+ shares, hinting at a cautious view on its AI‑driven future.

Core Scientific’s new RSU grant for Chief Accounting Officer Ray Jorge L. shows strong executive confidence amid insider selling, signaling continued growth potential and aligning leadership with shareholder interests.

Core Scientific insider sale reveals liquidity strategy amid bullish market – explore the impact on future growth and investor sentiment.